So, the aim of this work is to establish the relation between calreticulin, factor V Leiden, prothrombin G20210A, and MTHFR mutations in ET patients and the thrombotic risk of these patients, as independent factors or as covariates with other biological features. The gene discussed is CALR; the disease is essential thrombocythemia.